Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21681928 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Intervention: Drug: amifostine trihydrate

Indicates status has not been verified in more than two years